In the media

<p>Source: IRB Barcelona</p>
15 Nov 2018 - TV3 & OTHER MEDIA

TV3, RAC1, ABC, World Pharma News, Neuro Science, among other national and international media, have published articles about the research from the Peptides and Proteins Lab at IRB Barcelona. The study in question is inspired on the scorpion venom to deliver medicines to brain. The scientists have modified a peptide from the venom and used it as a shuttle to transport drugs across the barrier that protects the brain.

Link to TV3

Link to...

<p>Salvador Aznar Benitah, head of the IRB Barcelona group "Stem Cells and Cancer". (Photo: Battista-Minocri, IRB)</p>
12 Nov 2018 - Catalunya Ràdio

Catalunya Ràdio interviewed Salvador Aznar Benitah, head of the Stem Cells and Cancer Lab at IRB Barcelona, and co-author of a recent study indicating that skin cells lose their identity over time and starts behaving like fat cells and thus do not exert their protective action.

Link to Catalunya Ràdio

 

<p>Holger Heyn (CNAG-CRG), Salvador Aznar Benitah y Marion Salzer (IRB Barcelona)</p>
9 Nov 2018 - El Punt Avui & other media

El Punt Avui, La Vanguardia, Antena 3, EFE and El Diario Vasco, among other media, have published articles about the recent research led by IRB Barcelona and CNAG-CRG, which highlights that skin ages because its cells “forget” their function and stop secreting collagens and other proteins. The study has been published in the journal Cell and could have therapeutic applications aiming to help aged skin to form scar tissue faster and more efficiently after damage or after an operation.

Enlace a Antena 3

Enlace a...

<p>Núria López-Bigas, head of the Biomedical Genomics Lab at IRB Barcelona</p>
7 Nov 2018 - Muy Interesante & other media

Muy Interesante, El Punt AVui, Diario Médico, Laboratory Journal and Federfarma, among other national and international media, have published articles about the research led by Núria López-Bigas, ICREA researcher at IRB Barcelona and that explains the origin of the mysterious periodicity in the genome.

Link to Muy Interesante

Link to Diario Médico

Link to...

<p>Roger Gomis, head of the Growth Control and Cancer Metastasis Lab</p>
5 Nov 2018 - La Vanguardia

The “Dinero” supplement of the newspaper La Vanguardia has interviewed Roger Gomis, ICREA researcher at IRB Barcelona, about Inbiomotion, a spin-off from the institute and ICREA. This company, which came about from biomedical research and an entrepreneurial spirit, develops and commercialises a diagnostic test that allows the identification of those breast cancer patients most likely to develop bone metastasis. “It is very satisfying that an idea that arose in a lab has found a favourable environment in Barcelona in which to take a potentially life-saving product onto the market,” says Gomis.

Link to...

<p>Photo: Xavier Ayala</p>
5 Nov 2018 - Segre

The websites of Segre and Lleida have published an article on the latest Vi per Vida event, held last Sunday at "Les Obagues" ecocentre in Juneda. Organised by the sommelier Xavier Ayala and the Tastavins Juneda Association, this initiative aims to raise funds for cancer research and metastasis carried out at IRB Barcelona.

Link to Segre

Link to Lleida.com

<p>Francesc Posas, director at IRB Barcelona</p>
22 Oct 2018 - PharmaBoardroom

The magazine Pharma Board Room has published an interview with Francesc Posas, director of IRB Barcelona, in which he explains the role of the institute as a bridge between basic research and specific treatments for patients: "IRB Barcelona is well positioned. Our exceptional faculty is producing some excellent science that will undoubtedly improve people's quality of life," said Posas.

Link to Pharma Board Room

<p>Francesc Posas, director at IRB Barcelona</p>
15 Oct 2018 - TV3

TV3 has reported on the campaign "Legado Solidario", an initiative involving 25 organisations, among them IRB Barcelona. In the report, Francesc Posas, director of the institute, talks about the bequest of 1.5 € million the centre received last year to support cancer research and metastasis.

Link to TV3

<p>Source: TV3</p>
10 Oct 2018 - TV3 & OTHER MEDIA

La Razón, TV3, La Sexta, Men's Health and New Atlas, among other local and international media, have published an article about the study done at IRB Barcelona and Vrije Universiteiti Brussel. The study has identified camelid nanobodies able to block EGF, a protein that is abundant in tumour cells and that helps them to proliferate.

Link to TV3

Link to ...

<p>Angel R. Nebreda, head of the Signalling and Cell Cycle Laboratory at IRB Barcelona</p>
7 Oct 2018 - La Opinión de Zamora

The newspaper "La Opinion" interviewed Angel R. Nebreda, ICREA researcher at IRB Barcelona, who will be participating in a conference on breast cancer on October 18 within the Health Forums of La Opinion and El Correo de Zamora. In this conference, he will be talking about his work in the lab on tumour formation and his efforts to unravel the mechanisms responsible for the transformation of normal tissue to a tumour.

Link to La Opinión